Empowering healthcare with AI: LungDiag NLP system transforms respiratory disease diagnosis

FHS
July 14, 2023
10:06 am

An artificial intelligence (AI) -based diagnostic system, LungDiag, to diagnose respiratory diseases.

Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product | Psychedelic Invest

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company

April 18, 2024

FDA approves Roche’s Ocrevus Zunovo

Ocrevus Zunovo’s most common adverse events were injection reactions, which were either mild or moderate in nature. Credit: pedro7merino/Shutterstock. Roche has secured approval from the

September 16, 2024

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.